MedWatch

Biotech boss in the US: Pharma companies have themselves to blame

The pharmaceutical industry is largely to blame for the current situation in the US with the increased price pressure and political focus on the sector, believes Jesper Høiland, former VP of Novo Nordisk and currently President and CEO of US Radius Health. He predicts that the "freedom of pricing" will not exist in 5-10 years.

Photo: /Ritzau Scanpix/Niels Ahlmann Olesen/

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Ny liste: Novo-toppen blandt de mest magtfulde i Danmark

Toppen af dansk magtelite er spækket med Novo-bosser, der indtager seks ud af 100 pladser over de mest magtfulde personer i Danmark i 2018, viser ny magtanalyse, der også afslører, at det Novo-koncernen undtaget er sparsomt med islæt fra dansk life science – én anden medico-boss har dog sneget sig med blandt de 100 med mest magt.

Related articles